Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at BCG and hyperthermia treatment for people with transitional cell bladder cancer (HYMN)

Overview

Cancer types:

Bladder cancer, Transitional cell cancer

Status:

Results

Phase:

Phase 3

Details

This trial compared standard treatment (including BCG) and hyperthermia treatment for early stage transitional cell bladder cancer that had come back. It was supported by Cancer Research UK.

This trial was open for people to join between 2010 and 2013, and the research team first published results in 2018.

Recruitment start: 1 May 2010

Recruitment end: 19 July 2013

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor John Kelly

Supported by

Cancer Research UK

Kyowa Hakko UK Limited

Medical Enterprises BV

University College London (UCL)

University of Birmingham

Other information

This is Cancer Research UK trial number CRUK/09/012.

Last reviewed: 07 Jul 2020

CRUK internal database number: 2411

Help and support